医学
肥厚性心肌病
心脏病学
内科学
心脏淀粉样变性
心肌病
疾病
物候学
淀粉样变性
重症监护医学
心力衰竭
生物化学
基因
突变体
化学
作者
Gherardo Finocchiaro,Nabeel Sheikh,Elena Biagini,Michael Papadakis,N Maurizi,Gianfranco Sinagra,Antonio Pelliccia,Claudio Rapezzi,Sanjay Sharma,Iacopo Olivotto
出处
期刊:Heart Rhythm
[Elsevier BV]
日期:2019-08-10
卷期号:17 (1): 142-151
被引量:130
标识
DOI:10.1016/j.hrthm.2019.07.019
摘要
In an era of rapid technological development and evolving diagnostic possibilities, the electrocardiogram (ECG) is living an authentic “renaissance” in myocardial diseases. To date, the ECG remains an irreplaceable first step when evaluating patients with hypertrophic cardiomyopathy (HCM) and an abnormal ECG may be the only manifestation of disease at an early stage. In some instances, specific electrical anomalies may differentiate HCM from phenocopies such as cardiac amyloidosis and glycogen storage diseases. The exponential growth in knowledge of the complexity of HCM has led to new challenges in terms of early identification of the disease, differential diagnosis, risk stratification, and development of targeted therapies. In this scenario, the apparently “old fashioned” ECG and the array of ECG-based techniques, ranging from Holter monitoring and loop recorders to exercise testing, are as contemporary as ever. In the present review, we discuss the current role of the ECG in the diagnosis and management of HCM, focusing on various clinical settings where its appropriate use and interpretation can make a difference. In an era of rapid technological development and evolving diagnostic possibilities, the electrocardiogram (ECG) is living an authentic “renaissance” in myocardial diseases. To date, the ECG remains an irreplaceable first step when evaluating patients with hypertrophic cardiomyopathy (HCM) and an abnormal ECG may be the only manifestation of disease at an early stage. In some instances, specific electrical anomalies may differentiate HCM from phenocopies such as cardiac amyloidosis and glycogen storage diseases. The exponential growth in knowledge of the complexity of HCM has led to new challenges in terms of early identification of the disease, differential diagnosis, risk stratification, and development of targeted therapies. In this scenario, the apparently “old fashioned” ECG and the array of ECG-based techniques, ranging from Holter monitoring and loop recorders to exercise testing, are as contemporary as ever. In the present review, we discuss the current role of the ECG in the diagnosis and management of HCM, focusing on various clinical settings where its appropriate use and interpretation can make a difference.
科研通智能强力驱动
Strongly Powered by AbleSci AI